Scribd Logo
Upload

Welcome to Scribd!

  • KEMRI Gets Ksh.100 M For Vaccine Manufacturing in The Country

    Uploaded by

    Danisa backup
    8 views2 pages
    The Kenyan government has provided 100 million Kenyan shillings to the Kenya Medical Research Institute (KEMRI) to establish a training hub for vaccine manufacturing in Kenya. The funding will be used to recruit and train the first cohort of students from local universities to learn vaccine manufacturing. The trainees will also complete internships at vaccine companies in Europe, Korea, and Japan. KEMRI will also recruit Kenyan postdoctoral researchers from abroad to work on vaccine research and development projects. The goal is to make Kenya more self-sufficient in vaccine production, as support from organizations like GAVI will end in 2027.

    Original Description:

    Original Title

    KEMRI-gets-Ksh.100-m-for-vaccine-manufacturing-in-the-country

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The Kenyan government has provided 100 million Kenyan shillings to the Kenya Medical Research Institute (KEMRI) to establish a training hub for vaccine manufacturing in Kenya. The funding will be used to recruit and train the first cohort of students from local universities to learn vaccine manufacturing. The trainees will also complete internships at vaccine companies in Europe, Korea, and Japan. KEMRI will also recruit Kenyan postdoctoral researchers from abroad to work on vaccine research and development projects. The goal is to make Kenya more self-sufficient in vaccine production, as support from organizations like GAVI will end in 2027.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    8 views2 pages

    KEMRI Gets Ksh.100 M For Vaccine Manufacturing in The Country

    Uploaded by

    Danisa backup
    The Kenyan government has provided 100 million Kenyan shillings to the Kenya Medical Research Institute (KEMRI) to establish a training hub for vaccine manufacturing in Kenya. The funding will be used to recruit and train the first cohort of students from local universities to learn vaccine manufacturing. The trainees will also complete internships at vaccine companies in Europe, Korea, and Japan. KEMRI will also recruit Kenyan postdoctoral researchers from abroad to work on vaccine research and development projects. The goal is to make Kenya more self-sufficient in vaccine production, as support from organizations like GAVI will end in 2027.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    I n Search of Better Health

    PRESS RELEASE

    To: News Editors

    Subject: Government gives KEMRI KES 100 million to set-up training hub for vaccine
    manufacturing in the country.

    Date: Monday, 24th, April 2023


    The Government has made good its pledge to KEMRI by advancing Kes. 100 million
    to establish a training hub for vaccine manufacturing in the country. The pledge for
    funding was made by President William Ruto during his recent tour of Brussels in
    Belgium during which the president announced Kenya’s commitment to have local
    training hub for manufacturing of vaccines and other medical products as a top
    priority for his government.

    The funding to KEMRI will be used to recruit the first cohort of trainees in vaccine
    manufacturing who will include highly talented graduating students from local
    universities competitively recruited to join KEMRI for the programme. As part of
    the curriculum, the trainees will be attached to vaccine manufacturing companies
    in Europe, Korea and Japan to for in-depth practical exposure.

    The program shall also recruit Kenya postdoctoral fellows from the diaspora to
    work with KEMRI to carry out Research and Development Projects under KEMRI
    scientists on vaccine development.

    Page 1 of 2
    “We have a very highly talented team of Kenyans out there in USA, Canada, Europe
    among others who are completing or have completed their PhD programs in
    vaccine and drug research that KEMRI will be reaching out to,” Prof. Elijah Songok,
    Acting Director General, KEMRI said while welcoming the government’s move to
    fund the initiative.

    “Many of them are looking for a way to contribute to such home initiatives but
    there has been limited platforms for engagement. KEMRI shall provide one such an
    avenue,’’ Prof. Songok intimated.

    Apart from the lessons learnt from the COVID-19, Kenya is racing against time to
    be self sustainable in vaccine. GAVI (Global Vaccine Initiative) the organization that
    has been supporting Kenya and other countries to access affordable vaccines for
    their Immunization programs shall cease support from 2027.

    For more information, please contact Wodera James on Email: jwodera@kemri.go.ke,


    0722767682.

    Page 2 of 2

    You might also like